Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...

Guggenheim analysts revised their price target for Eli Lilly (NYSE:LLY) shares, reducing it to $973.00 from the previous $995 ...

Driven by the growing use of Indic languages for digital content, the internet user base in India is set to surpass 900 million by 2025, driven by the growing use of Indic languages for digital ...

New data from the American Cancer Society found cancer rates in women surpassed males for the first time. The 2025 ACS Cancer Facts and Figures detected more female cases across a large age range ...

Polish Prime Minister Donald Tusk advocated for increased defense spending across NATO on Jan. 15, arguing that if all European members matched Poland’s spending, NATO’s defense budget would be ten ...

Today we've published final guidance for the weight loss medication tirzepatide (mounjaro). It means the phased roll out – set out in our guidance – will begin in 2025. In 2022, the government ...

The war between Bleach fans and the Narutoverse has been since the early 2000s when these series reached their prime. However, the latter is still introducing new beings (power creeps), one of ...

Blood glucose reduction and insulin secretion levels from the oral DehydraTECH-tirzepatide were comparable to injected Zepbound® KELOWNA, BC / ACCESSWIRE / January 14, 2025 / Lexaria Bioscience ...

Blood glucose reduction and insulin secretion levels from the oral DehydraTECH-tirzepatide were comparable to injected Zepbound® KELOWNA, BC / ACCESSWIRE / January 14, 2025 / Lexaria ...

(Photo by Brendan Smialowski / AFP) Outgoing US President Joe Biden said Monday the United States would remain the world’s predominant superpower and that China would “never surpass us.” ...